ÌÇÐÄvlog

[Skip to Navigation]
Sign In
Editorial
´¡³Ü²µ³Ü²õ³ÙÌý14, 2024

Vaccine Mandates for Health Care Workers—An Effective Policy Tool for Past and Future Pandemics

Author Affiliations
  • 1Division of Allergy & Infectious Diseases, Department of Medicine, University of Washington, Seattle
JAMA Netw Open. 2024;7(8):e2426820. doi:10.1001/jamanetworkopen.2024.26820

COVID-19 vaccines reduce the risk of infection, severe disease, long COVID, and death.1-5 Given the effectiveness of these tools, the reasonable next question is how to maximize their use to protect the greatest number of people from harm, especially those at greater risk for infection and disease progression. Although COVID-19 vaccines were free and obtainable in 2021 and as early as December 2020 for some health care workers (HCWs), a considerable proportion of people in the US chose not to get vaccinated.6-8 This fact was of increasing concern as novel variants began to appear in the first half of 2021—first Alpha and Gamma followed by the Delta wave during the summer and fall of 2021. The Delta wave was associated with a dramatic increase in infection and hospitalization rates, disproportionally affecting unvaccinated individuals9,10 and peaking nationally in September 2021.11 As a result, policymakers at the federal, state, and local levels began to develop interventions, including vaccine mandates, for various sectors, including state workers, police officers, firefighters, and HCWs. Importantly, while the science supporting vaccines at the individual level at the time was robust, the impact of policy tools like vaccine mandates was not well understood despite the widespread use of similar vaccine requirements for other infectious diseases. Wang and colleagues12 investigated this challenging and critically important question: do public policies that required health care workers to get vaccinated increase vaccine uptake?

To address this question, Wang et al12 evaluated 16 states with vaccine mandates in 2021 that required HCWs to be vaccinated against COVID-19 compared with 29 states that did not require vaccination. The vaccination status of 31 142 HCWs aged 25 to 64 years was obtained from the Household Pulse Survey13 between May and October 2021. The study period included the 2 months prior to the first state mandate through October 11, 2021. The end of the study period was chosen to prevent potential attribution of vaccination decisions to the HCW vaccine mandate that was implemented by the Centers for Medicare & Medicaid Services (CMS) in early November 2021. For the analysis, Wang et al12 used a standard staggered difference-in-differences event study model to capture the outcomes of the separate times of mandate implementation and differences in vaccine uptake among state HCW populations.

Using 2-week survey blocks for data collection and analysis, by the second week after a mandate was implemented, Wang et al12 found an increase in the proportion of HCWs ever vaccinated or who had completed or intended to complete the primary vaccination series. This represented a nearly 4% increase in vaccination rates in mandate states compared with nonmandate states. The proportions returned to baseline by the following 2-week block and remained close to baseline through the rest of the study period. In states with a test-out option, there was no detectable increase in vaccination rates even in the early period (2 weeks after mandate implementation). When analyses were stratified by states with no test-out option, statistically significant increases in HCW vaccination were seen in the first and second 2-week blocks. Interestingly, HCWs aged 25 to 49 years had the largest increases in vaccination after mandate implementation, ranging from an almost 6% increase in the first 2 weeks to just over 7% in weeks 3 and 4.

These results join those of other studies that found an association between vaccine mandates and increased vaccinations in specific populations.14-17 Although HCWs in the study by Wang et al12 had high rates of vaccination initially, mandates were associated with increases in baseline proportions ranging from 84% to 88%, usually within the first 4 weeks after the mandate. The rate of increase was likely affected by the planned implementation of the CMS mandate as well as local mandates from hospitals and health care systems, including in nonmandate states, both of which may have diluted the measured effect estimates for the state mandates. Importantly, researchers are gaining more information on the specific tools that can be used for employer vaccine mandate policies, including not having a test-out option.

Assuming that other studies will continue to replicate these findings, other questions about mandates remain unanswered. Vaccination mandates are sociopolitical decisions meant to increase the safety of the population, but how much of an increase in vaccination uptake is needed to warrant them? How is that increase measured, especially when faced with a novel pathogen like SARS-CoV-2? What is the ethical framework for developing a mandate? In the face of a novel pandemic, mandates may generate controversy even among the vaccinated population and are complicated by a significant volume of misinformation and disinformation.18,19 Studies like that by Wang et al12 provide more information that could be used to design mandates and communicate the impact of future mandates, providing much needed and better measures of the perceived tradeoffs of governmental action in preparation for the next pandemic and in the prevention of nonpandemic infectious diseases.

Back to top
Article Information

Published: August 14, 2024. doi:10.1001/jamanetworkopen.2024.26820

Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2024 Lynch JB. ÌÇÐÄvlog Open.

Corresponding Author: John B. Lynch, MD, MPH, Division of Allergy & Infectious Diseases, Department of Medicine, University of Washington, Harborview Medical Center, 325 9th Avenue, Box 359778, Seattle, WA 98104 (jblynch@uw.edu).

Conflict of Interest Disclosures: None reported.

References
1.
Benenson  S, Oster  Y, Cohen  MJ, Nir-Paz  R.  BNT162b2 mRNA COVID-19 vaccine effectiveness among health care workers.   N Engl J Med. 2021;384(18):1775-1777. doi:
2.
Fowlkes  A, Gaglani  M, Groover  K, Thiese  MS, Tyner  H, Ellingson  K; HEROES-RECOVER Cohorts.  Effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infection among frontline workers before and during B.1.617.2 (Delta) variant predominance—eight US locations, December 2020-August 2021.   MMWR Morb Mortal Wkly Rep. 2021;70(34):1167-1169. doi:
3.
Pilishvili  T, Fleming-Dutra  KE, Farrar  JL,  et al; Vaccine Effectiveness Among Healthcare Personnel Study Team.  Interim estimates of vaccine effectiveness of Pfizer-BioNTech and Moderna COVID-19 vaccines among health care personnel—33 US sites, January-March 2021.   MMWR Morb Mortal Wkly Rep. 2021;70(20):753-758. doi:
4.
Skowronski  DM, De Serres  G.  Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine.   N Engl J Med. 2021;384(16):1576-1577. doi:
5.
Thompson  MG, Burgess  JL, Naleway  AL,  et al.  Interim estimates of vaccine effectiveness of BNT162b2 and mRNA-1273 COVID-19 vaccines in preventing SARS-CoV-2 infection among health care personnel, first responders, and other essential and frontline workers—eight US locations, December 2020-March 2021.   MMWR Morb Mortal Wkly Rep. 2021;70(13):495-500. doi:
6.
Dror  AA, Eisenbach  N, Taiber  S,  et al.  Vaccine hesitancy: the next challenge in the fight against COVID-19.   Eur J Epidemiol. 2020;35(8):775-779. doi:
7.
Dzieciolowska  S, Hamel  D, Gadio  S,  et al.  COVID-19 vaccine acceptance, hesitancy, and refusal among Canadian healthcare workers: a multicenter survey.   Am J Infect Control. 2021;49(9):1152-1157. doi:
8.
Paris  C, Bénézit  F, Geslin  M,  et al.  COVID-19 vaccine hesitancy among healthcare workers.   Infect Dis Now. 2021;51(5):484-487. doi:
9.
Huang  E, Kurkure  S, Seo  Y, Lau  K, Puglisi  J.  The effectiveness of vaccination on the COVID-19 epidemic in California.   Am J Infect Control. Published online May 30, 2024. doi:
10.
Lin  L, Demirhan  H, P Johnstone-Robertson  S, Lal  R, M Trauer  J, Stone  L.  Assessing the impact of Australia’s mass vaccination campaigns over the Delta and Omicron outbreaks.   PLoS One. 2024;19(4):e0299844. doi:
11.
Centers for Disease Control and Prevention. COVID-NET interactive dashboard. Updated May 28, 2024. Accessed June 1, 2024.
12.
Wang  Y, Stoecker  C, Callison  K, Hernandez  JH.  State COVID-19 vaccine mandates and uptake among health care workers in the US.   JAMA Netw Open. 2024;7(8):e2426847. doi:
13.
US Census Bureau. Household Pulse Survey: measuring emergent social and economic matters facing US households. Accessed June 1, 2024.
14.
Howard-Williams  M, Soelaeman  RH, Fischer  LS, McCord  R, Davison  R, Dunphy  C.  Association between state-issued COVID-19 vaccine mandates and vaccine administration rates in 12 US states and the District of Columbia.   JAMA Health Forum. 2022;3(10):e223810. doi:
15.
Juarez  R, Siegal  N, Maunakea  AK.  The effects of COVID-19 vaccine mandates in Hawaii.   Vaccines (Basel). 2022;10(5):773. doi:
16.
McGarry  BE, Gandhi  AD, Syme  M, Berry  SD, White  EM, Grabowski  DC.  Association of state COVID-19 vaccine mandates with staff vaccination coverage and staffing shortages in US nursing homes.   JAMA Health Forum. 2022;3(7):e222363. doi:
17.
Okpani  AI, Lockhart  K, Barker  S, Grant  JM, Yassi  A.  Did the health care vaccine mandate work? an evaluation of the impact of the COVID-19 vaccine mandate on vaccine uptake and infection risk in a large cohort of Canadian health care workers.   Am J Infect Control. 2024;S0196-6553(24)00494-2. doi:
18.
De Nicola  G, Tuekam Mambou  VH, Kauermann  G.  COVID-19 and social media: beyond polarization.   Proc Natl Acad Sci U S A Nexus. 2023;2(8):pgad246.
19.
Rao  R, Koehler  A, Beckett  K, Sengupta  S.  COVID-19 vaccine mandates for healthcare professionals in the United States.   Vaccines (Basel). 2022;10(9):1425. doi:
×